The drugs regulator in India has asked all states to prohibit the sale of drugs online to prevent medicine abuse, according to a report.

A senior government official at the Central Drugs Standard Control Organisation (CDSCO) in India has reportedly claimed the CDSCO will ask all states to enforce a rule to prevent online medicines sales, according to Reuters.

The country has not finalised regulations for online pharmacies, despite several companies experiencing recent growth online, reports the outlet.

Last December, the Delhi High Court ordered the government to prohibit online sales of drugs in order to prevent patient medicine abuse. The current reminder to state authorities in the rest of India is to support this decision and stop all online sales for the time being. 

According to the outlet, online pharmacies can harm traditional business by providing steep discounts to customers. They can also encourage medicine abuse by allowing patients to order multiple medicines using one prescription.

However, the announcement has purportedly raised concern in the industry that online businesses will be negatively impacted.

Source: europeanpharmaceuticalreview

Recommended pharmaceutical suppliers on OKCHEM: 

Hunan Huari Pharmaceutical Co.Ltd

Kaiping Genuine Biochemical Pharmaceutical Co., Ltd

Zhejiang Davi Pharmaceutical Co., Ltd.

Recommended news in the pharmaceutical industry: 

New ‘smart pill’ technology reports 100% success rate
Chinese GMP Certification is Officially Canceled as of December 1st 2019
Drug prices in China cut by up to 61 percent for reimbursement scheme list
Campaign calls for more effort to combat counterfeit medicines
Facts about Sodium carboxymethyl starch Uses
New lymphoma drug! Roche's first CD79b target ADC drug Polivy qualified as orphan drug to treat DLB.
The newly revised Drug Administration Law of China to take effect on December 1, 2019 for better regulation of drug production
2019 China Vitamin C Export, Market Structure and Prospect Introduction